✦ LIBER ✦

5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis

✍ Scribed by Czibere, A; Bruns, I; Kröger, N; Platzbecker, U; Lind, J; Zohren, F; Fenk, R; Germing, U; Schröder, T; Gräf, T; Haas, R; Kobbe, G

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase I/II Trial of Combination of PKC

✍ Nazha, Aziz; Kantarjian, Hagop; Borthakur, Gautam; Kadia, Tapan; Faderl, Stefan; 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 76 KB

Efficacy of a 3-day, low-dose treatment

✍ Lübbert, M; Bertz, H; Wäsch, R; Marks, R; Rüter, B; Claus, R; Finke, J 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 164 KB

Combining Azacitidine (Vidaza®, Aza) and

✍ T. Schroeder; A.G. Czibere; N. Kröger; U. Platzbecker; G. Bug; L. Uharek; T. Luf 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB